Authority: IC 16-19-3-4; IC 16-41-2-1
Affected: IC 16-41-2; IC 16-41-9
Sec. 133.
The specific control measures for Staphylococcus aureus, vancomycin resistant level >= 8 µg/mL, or severe Staphylococcus aureus in a previously healthy person are as follows:
(1) An investigation by the department in collaboration with the local health officer shall be performed within seventy-two (72) hours to:(A) verify resistant or intermediate resistant culture isolate to vancomycin; and(B) provide antibiotic susceptibility results for severe Staphylococcus aureus infection in a previously healthy person that results in death or admission to an intensive care unit. For purposes of this section, "previously healthy person" means a person who has not been hospitalized or had surgery, dialysis, or residency in a long term care facility in the past year and did not have an indwelling catheter or percutaneous medical device at the time of culture. The investigation includes laboratory verification of resistance. Abrupt increases in the prevalence of the disease in the community shall be investigated for a common source.
(2) For hospitalized patients, contact precautions are required.(3) Concurrent disinfection is required for all: (A) discharges from the skin, wound, or burn; and(B) articles contaminated with discharges. Fecal material may be disposed of in a sanitary sewer.
(4) Quarantine is not applicable.(5) Immunization is not available. Protection of contacts is not applicable.(6) Case definition is established by the department.Indiana State Department of Health; 410 IAC 1-2.5-133; filed 11/25/2015, 2:54 p.m.: 20151223-IR-410150039FRAReadopted filed 11/12/2021, 8:41 a.m.: 20211208-IR-410210385RFA